Nabil Arrach, CEO of Progenesis, says the company is using cutting-edge technology in genomic sequencing to screen embryos for disease. He is joined in the lab by research associate Eva Martinez.

Nabil Arrach, CEO of Progenesis, says the company is using cutting-edge technology in genomic sequencing to screen embryos for disease. He is joined in the lab by research associate Eva Martinez.

— One of the more controversial topics in diagnostics today is the practice of reproductive genetic testing, which science fiction would have us believe will lead to designer babies with perfect features...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129